Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Adenosine kinase inhibition promotes survival of fetal adenosine deaminase–deficient thymocytes by blocking dATP accumulation
C. Justin Van De Wiele, … , Hong Jiang, Linda F. Thompson
C. Justin Van De Wiele, … , Hong Jiang, Linda F. Thompson
Published August 1, 2002
Citation Information: J Clin Invest. 2002;110(3):395-402. https://doi.org/10.1172/JCI15683.
View: Text | PDF
Article Genetics

Adenosine kinase inhibition promotes survival of fetal adenosine deaminase–deficient thymocytes by blocking dATP accumulation

  • Text
  • PDF
Abstract

Research Article

Authors

C. Justin Van De Wiele, James G. Vaughn, Michael R. Blackburn, Catherine A. Ledent, Marlene Jacobson, Hong Jiang, Linda F. Thompson

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Targeted deletion of the adenosine A2aR or A3R does not correct the effe...
Targeted deletion of the adenosine A2aR or A3R does not correct the effects of ADA deficiency in FTOC. FTOCs were performed at day 15 of gestation with fetal thymuses from A2aR–/– and A3R–/–Adam1/m1 mice and appropriate controls. A2aR+/+ (a and b) and A2aR–/– (c and d) fetal thymic lobes were cultured for 8 days in the presence (b and d) or absence (a and c) of 5 μM dCF. A3R–/–Ada+ (e) and A3R–/–Adam1/m1 (f) fetal thymic lobes were cultured for 5 days. At the end of culture, thymocytes were harvested, counted, and stained with FITC-anti-CD4, PE-anti-CD8, and PI to exclude dead cells. The data are representative of one experiment out of two.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts